Dr Haight on Predictors of Treatment Toxicity in Gynecologic Malignancies

Paulina J Haight, MD, discusses predictors of toxicity and treatment response with lenvatinib and pembrolizumab in patients with gynecologic malignancies.

Related Keywords

Ohio State University ,Ohio ,United States ,Paulinaj Haight , ,Ohio State University Cancer Center ,Ohio State College Of Medicine ,Ohio State College ,Go Winter Meeting ,Onclive Tv ,Gynecologic Oncology ,